Greenwich LifeSciences holds 2024 annual meeting; all director nominees elected, equity plan amendment approved

Greenwich LifeSciences, Inc.

All five director nominees elected with majority support; no votes against, only abstentions and broker non-votes.
Ratification of RBSM as independent auditor for FY2024 approved: 9,224,694 for, 10,077 against, 2,644 abstain.
Amendment to 2019 Equity Incentive Plan to increase reserved shares from 1.5M to 4.0M approved: 8,067,672 for, 164,730 against.
Total shares represented at meeting: 12,848,165, constituting a quorum.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.